Network Crawling & Curation | 2026-05-29 | AI: Cibo

Three Hong Kong IPO analysis articles from WeChat Ask is Add More, crawled and curated for reference. The author is an independent retail investor with a direct, no-BS style with solid data.

N Network Crawling Disclaimer

Source: WeChat public account Ask is Add More, independent retail investor.
Method: Auto-crawled and curated by AI assistant Cibo. This article does NOT represent views of Panda Securities or Cibo.
Risk Warning: All subscription plans and analysis are the author personal trading records ONLY. Not investment advice. Investment involves risk.
Completeness: Original images/formats may be lost during crawling. See original link for full article.
Copyright: Belongs to original author. Contact us for removal if undesired.

1. Tianchen Bio-B (01779.HK) IPO Analysis

Original: View Source on WeChat

Company	Tianchen Bio-B (01779.HK)
IPO Price	HKD 96.00
Lot Size	50 shares
Issue Ratio	19.13%
Entry Fee	HKD 4,851.44
Greenshoe	Yes
Cornerstone	49.96%
Market Cap	HKD 7.1B

Company Overview

Clinical-stage biopharma founded 2020, Shanghai/Suzhou. Focuses on biologics for allergic and autoimmune diseases.

Financials (2 years to Dec 2025)

Other income: RMB 3.07M | 5.59M (YoY +81.95%)
R&D: RMB 98M | 127M (YoY +29.10%)
Net loss: RMB -137M | -176M (widening)
Operating CF: RMB -121M | Cash: ~RMB 95M

Sponsor & Cornerstones

Sponsor: Guojin Securities (mediocre, first IPO in 2026). Cornerstone: ~50%, mostly pharma institutions, first-tier quality.

Allocation

19% issue, Mechanism B, 28,388 public lots, HKD 136M public offer. With 3 concurrent IPOs, if ~3,000x subscription: Group A tail ~50%, Group B head ~40%.

Three previous IPOs all popped. Sentiment remains hot. Play while you can.

Author Positions

Chuangxiang 3D (03388): Sold at open 36, no hesitation.
Shougang Langze (02553): Pass.
Dajin Heavy (01081): Discount not deep, maybe token cash play.
Longfeng (02290): Local stock gamble, boom or bust.

2. Shougang Langze (02553.HK) Subscription Plan

Original: View Source on WeChat

Company	Shougang Langze (02553.HK)
IPO Price	HKD 14.6 - 17.1
Lot Size	200 shares
Issue Ratio	10%
Entry Fee	HKD 3,454
Greenshoe	No
Cornerstone	None
Market Cap	HKD 5.84B - 6.84B

No fluff. Author Plan: PASS. Leaving for the destined.

Respect old glories of the market
Room for bold newcomers
Hands out for what is worthy
Turn away from what is empty
In uncertainty, only with conviction
Wait patiently

Author Positions

Chuangxiang 3D (03388): 2,000x subscription, entered lottery
Huaxida (00901): No allocation
Shenyanzhineng (02723): No allocation
Yunyinggu (03310): Allocated, chips sector up, looking good

3. Dajin Heavy Industry (01081.HK) IPO Analysis

Original: View Source on WeChat

Company	Dajin Heavy Industry (01081.HK, A: 002487)
IPO Price	Max HKD 66.40
Lot Size	100 shares
Issue Ratio	12%
Entry Fee	HKD 6,706.97
Greenshoe	Yes
Cornerstone	48.55%
Market Cap	HKD 48.1B (H-share HKD 5.775B)

Company Overview

Global leader in offshore wind power equipment. Nearly 20 years in new energy. Integrated fabrication+transport+delivery solutions. Expanding into ocean transport, ship design, wind port ops, new energy development. Transitioning from product supplier to system service provider.

2023-2025: Overseas revenue share surged 39.6% to 74.5%. First-supply vendor for RWE, Ocean Winds, Vestas. #1 in Europe offshore wind foundations at 29.1% market share (H1 2025), well ahead of #2 at 18.2%.

Financials (3 years to Dec 2025)

Revenue: RMB 4.325B | 3.780B | 6.174B (YoY +63.34%)
Net Profit: RMB 425M | 474M | 1.103B (YoY +132.82%)

Sponsor & Cornerstones

Sponsors: Huatai + China Merchants (track record: okay). Cornerstone ~50%: GIC Singapore, Hillhouse, UBS, Fullgoal. First-tier international backing.

Allocation

12% issue, Mechanism B, 86,966 public lots, HKD 577M public offer. Lots of supply. AH-listed, ~70%+ discount to A-shares. If margin subscription hits 500x, Group A tail and Group B head ~1-2 stable lots each.

Author Positions

Shenyanzhineng (02723): Absolute madness. Early sellers crying.
Longfeng (02290): Gamble play.
Tianchen Bio-B (01779): Most stable this batch.
Zhipu (02513): Drama today. Whoever bought my 3 lots at 130, give me a like!
Shougang Langze (02553): Sat out, watching others feast.

N Network Crawling Disclaimer

Source: WeChat public account Ask is Add More, independent retail investor.
Method: Auto-crawled and curated by AI assistant Cibo. This article does NOT represent views of Panda Securities or Cibo.
Risk Warning: All subscription plans and analysis are the author personal trading records ONLY. Not investment advice. Investment involves risk.
Completeness: Original images/formats may be lost during crawling. See original link for full article.
Copyright: Belongs to original author. Contact us for removal if undesired.

Crawled & curated by Cibo on 2026-05-29 | Source: WeChat Ask is Add More | For informational purposes only

Panda Securities Company Limited | SFC Licensed (CE No. BNC380) | Type 1, 2, 9

Blog